Elsevier

Research in Veterinary Science

Volume 63, Issue 2, September–October 1997, Pages 157-160
Research in Veterinary Science

Original article
In vitro susceptibilities of recent field isolates of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae to valnemulin (Econor®), tiamulin and enrofloxacin and the in vitro development of resistance to certain antimicrobial agents in Mycoplasma hyopneumoniae

https://doi.org/10.1016/S0034-5288(97)90010-2Get rights and content

Abstract

The in vitro activities of valnemulin (Econor®) and two other antimicrobial agents were determined against recent field strains of Mycoplasma hyopneumoniae and Mycoplasma hyosynoviae using a broth microdilution method. Valnemulin showed exceptional activity against M hyopneumoniae (MIC90 0·0005 μg ml−1) and M hyosynoviae (MIC range 0·0001 μg ml−1 to 0·00025 μg ml−1) field strains. Tiamulin was 100-fold less active (MIC90 0·05 μg ml−1) and enrofloxacin 20-fold less active (MIC90 0·01 μg ml−1) than valnemulin against M hyopneumoniae field isolates and 20-fold to 25-fold less active (MIC range 0·0025 μg ml−1 to 0·005 μg ml−1) and 400-fold to 500-fold less active (MIC range 0·05 μg mlt1̄ to 0· 1 μg ml−1) respectively against M hyosynoviae field isolates. No significant resistance developed to valnemulin or tiamulin in the type strain of M hyopneumoniae (strain J) or in a recent field isolate (MEVT G23) exposed to 10 in vitro passages in broths containing these antibiotics. Only slight resistance to oxytetracycline was observed. High resistance to tylosin developed in both M hyopneumoniae strains within five to seven in vitro passages in tylosin-containing broth. Providing that similar results are obtained in vivo under field conditions, valnemulin may well prove to be effective in the treatment of enzootic pneumonia and acute polyarthritis in pigs.

References (17)

There are more references available in the full text version of this article.

Cited by (87)

  • Antimicrobial susceptibility monitoring of Mycoplasma hyopneumoniae isolated from seven European countries during 2015–2016

    2021, Veterinary Microbiology
    Citation Excerpt :

    However, recent antimicrobial susceptibility data of M. hyopneumoniae is rather limited, in contrast to Mycoplasma bovis susceptibility data (e.g., Heuvelink et al., 2016; Cai et al., 2019). Moreover, there are limitations in the available M. hyopneumoniae data, as published studies either have a limited number of isolates, or are only from one country (Hannan et al., 1997a; Vicca et al., 2004; Tavío et al., 2014). In other studies the epidemiological sampling framework, or herd information is either limited or absent (Hannan et al., 1997a,1997b).

View all citing articles on Scopus
View full text